Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
-
Publication Type:Journal article
-
Publication Sub Type:Article
-
Authors:Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK
-
Publisher:OXFORD UNIV PRESS INC
-
Publication date:15/04/2017
-
Pagination:1006, 1016
-
Journal:CLINICAL INFECTIOUS DISEASES
-
Volume:64
-
Issue:8
-
Status:Published
-
Print ISSN:1058-4838
-
Language:English
-
Keywords:Science & Technology, Life Sciences & Biomedicine, Immunology, Infectious Diseases, Microbiology, HIV, antiretroviral therapy, virological failure, second line, protease inhibitor, 1ST-LINE ANTIRETROVIRAL THERAPY, SUB-SAHARAN AFRICA, RESOURCE-LIMITED SETTINGS, DOSE LOPINAVIR-RITONAVIR, REVERSE-TRANSCRIPTASE, HEALTHY-VOLUNTEERS, DRUG-RESISTANCE, HIV-1, FAILURE, GAG
-
Full Text URL:
Abstract
No abstract found
› More search options
UCL Researchers
